Magnolia Medical Says Kurin Continues to Infringe Device Patents

Magnolia Medical Technologies Inc. continued its lengthy legal feud with Kurin Inc. accusing its competitor of creating infringing blood culture collection kits months after Kurin lost a $2.1 million patent suit.

Kurin “doubled down on its predatory business model” by creating the Kurin Jet blood collection product, Magnolia said in a complaint filed Monday in the US District Court for the Southern District of California. Kurin’s product and configurations use similar methods as U.S. Patent Nos. 9,855,002; 10,052,053; 11,529,081; 11,653,863 and 11,903,709, according to the complaint.

The ‘002 and ‘053 patents deal with using a device ...